ask="2.13"
ask_size="5000"
average_daily_volume="1876700"
bid="2.03"
bid_size="500"
book_value="1.37"
change="+0.13"
change_from_200_day_moving_average="-3.26"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-6.20"
change_From_52_week_low="0.82"
change_in_percent="+6.88%"
close="2.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.34"
ebitda="-82.29M"
eps_estimate_current_year="-0.21"
eps_estimate_next_quarter="-0.09"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="69541000"
high="2.09"
high_52_weeks="8.22"
last_trade_date="1/10/2017"
last_trade_price="2.02"
last_trade_size="19315"
last_trade_time="4:00pm"
low="1.79"
low_52_weeks="1.20"
market_capitalization="149.83M"
moving_average_200_day="5.28"
moving_average_50_day="2.08"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="1.90"
pe_ratio="N/A"
peg_ratio="-1.04"
percent_change_from_200_day_moving_average="-61.74%"
percent_change_from_50_day_moving_average="-2.79%"
percent_change_from_52_week_high="-75.43%"
percent_change_from_52_week_low="+68.33%"
previous_close="1.89"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.38"
price_per_sales="885.39"
revenue="158333.00"
shares_outstanding="74173000"
short_ratio="3.34"
stock_exchange="NMS"
symbol="ARWR"
volume="2788639"
weeks_range_52="1.20 - 8.22"
